Global University Venturing

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Educational data software developer Kidaptive had raised more than $30m from investors including Stanford-StartX Fund.

UF Innovate Ventures has contributed to a series B round for StrideBio, partially based on research into gene therapies at University of Florida.

Hanoi University of Science and Technology’s BK Fund has partnered ThinkZone for a $10m fund that will invest in domestic startups.

D1 Capital Partners has led a $102m series D round for Inflammatix, whose existing shareholders include Stanford-StartX Fund.

The spinout’s technology was fundamental to Oxford’s covid vaccine, prompting OSI and Future Planet Capital to back a $168m round.

IBM Ventures participated in a $20m round for the neurological disease diagnostics technology spinout of Tel Aviv University.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Miyako Capital has contributed to a series A round for the cancer vaccine developer, which expanded to Japan last year.

The money will fund the progress of the University of London-linked precision medicine developer's lead drug candidate into the clinic.

Osaka spinout Cuorips has added $14.7m to its coffers from investors including vehicles for the institution and Kyoto University, just three months after collecting $19.3m.